Pharma companies are as excited as anyone about the shift to value-based care and the ways that technology can enable it, but they’re increasingly skeptical about the speed of that change. At Health 2.0 this week in Santa Clara, California, at a panel moderated by Kian Beyzavi, principal investor at KBeyzavi and Associates, several innovation executives at pharmaceuticals talked about value-based...
By way of a contract with UK-based healthcare startup Cera, Uber will help facilitate faster patient care to those in England's National Health Service system by providing on-demand transportation for caregivers and patients between hospitals and homes. Cera originally launched the caregiver-patient matching service in November with a few smaller clinical organizations, and Uber acts as the...
About the author: Naomi Fried, PhD (@NaomiFried), is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation infrastructure consulting to healthcare stakeholders including pharma companies and providers. Her previous positions include the first Chief Innovation Officer at Boston Children’s Hospital, Biogen’s VP of Innovation and External Partnerships, and VP...
Pharmaceutical company Boehringer Ingelheim is partnering with Inovalon, a data analytics company that provides cloud-based platforms to the healthcare industry to facilitate the shift from volume to value-based care, on behalf of Boehringer Ingelheim’s diabetes alliance with Eli Lilly. Leveraging Inovalon’s platform, the partnership will work to support outcomes-based contracting, taking...
Madison, Wisconsin-based Propeller Health has closed a $21.5 million Series C financing round, with new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, plus existing investors Safeguard Scientifics and Social Capital. The funding will be used to further Propeller’s digitally-guided therapy platform.
Propeller’s aim is to simplify management of chronic respiratory diseases like asthma...
The future of pharma is going to involve some major culture shifts for a business that has long been focused on slow development cycles, proprietary molecules, and close-held secrets. That’s the word from representatives from Bayer, Boehringer Ingelheim, Healthware International and BTG, a group that ran the gamut from small to big pharma at yesterday’s Pharma Roundtable onsite at Health 2.0 in...
Qualcomm Life and Boehringer Ingelheim have announced that they will work together to develop the next generation of Boehringer's Respimat connected inhaler. Propeller Health, which developed the original connected inhaler for Boehringer, will continue to work with Boehringer to at least market the existing version of the device.
"The overall goal for Boehringer Ingelheim is to create health...
HealthPrize Technologies closed a series B round of financing, which included new and existing investors. The medication adherence company intends to use the funds to expand the team both internally and internationally. While the amount of this round remains undisclosed, the company had previously raised about $7 million from investors including Mansa Capital, dLife Founder Howard Steinberg and...
Larry Brooks, director of business innovation at Boehringer Ingelheim, took the stage in a fireside chat with Medullan EVP and Managing Director Jonathan Chen at MobiHealthNews 2016 in San Francisco last week. Brooks has been leading Boehringer's digital health group for the past five years, and he shed some light on how the pharma company's approach to the space has changed during that time.
"...
As we do every quarter, MobiHealthNews has rounded up our Q1 2016 coverage into a handful of longform stories. This section is on pharma. Skip ahead using these links to read Q1 digital health news roundups about providers, payers, M&A and funding.
Novartis
Novartis announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler...
